Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients

This study has been completed.
Information provided by (Responsible Party):
Bezmialem Vakif University Identifier:
First received: November 28, 2013
Last updated: May 15, 2014
Last verified: May 2014